CyanVac LLC, a clinical-stage biopharmaceutical company developing intranasal vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector, announced preclinical data in a hamster...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated efficacy and safety results from the teclistamab Phase 1/2 MajesTEC-1 study.1 Teclistamab is an...
Kintara Therapeutics, Inc.("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that the Company received...
NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, is increasing its capabilities in neurology companion diagnostics (CDx) and future...
WuXi Biologics ("WuXi Bio") , a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility...
